NTL Pill - orange oval, 19mm
Pill with imprint NTL is Orange, Oval and has been identified as Lapatinib Ditosylate 250 mg. It is supplied by Lupin Pharmaceuticals, Inc.
Lapatinib is used in the treatment of Breast Cancer, Metastatic; Breast Cancer and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Lapatinib 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NTL
Lapatinib Ditosylate
- Imprint
- NTL
- Strength
- 250 mg
- Color
- Orange
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors, HER2 inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- Manufacturer
- Natco Pharma Limited
- National Drug Code (NDC)
- 68180-0801
Related images for "NTL"
More about lapatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.